OCUL logo
OCUL NASDAQ US

Ocular Therapeutix, Inc. - Common Stock

Healthcare · Pharmaceuticals Website · IPO Jul 2014
$8.49
▲ +$0.16 (+1.92%)
Vol 4.4M
7
Quality Score
fail
Mkt Cap
$2.6B
ROE
-87.2%
Margin
-447.6%
D/E
27.35
Beta
0.89
52W
$6–$16

Wall Street Consensus

18 analysts · Apr 2026
6
Strong Buy
11
Buy
1
Hold
0
Sell
0
Strong Sell
94.4%
Buy Rating

Price Chart

Similar Stocks

PAHC
Phibro Animal Health Corp
P/E 22.4
$1.5B
NKTR
Nektar Therapeutics
$860.0M
DFTX
Definium Therapeutics Inc
INVA
Innoviva Inc
P/E 11.7
$1.5B
ANIP
ANI Pharmaceuticals Inc
P/E 43.7
$1.8B
AMLX
Amylyx Pharmaceuticals Inc
$1.3B

Earnings

Beat rate: 25.0%
Quarter EPS Est EPS Act Surprise
Dec 2025 $-0.33 $-0.29 +$0.04
Sep 2025 $-0.37 $-0.38 $-0.01
Jun 2025 $-0.36 $-0.39 $-0.03
Mar 2025 $-0.30 $-0.38 $-0.08

Fundamentals Trend

Metric 2025-06-30 2025-09-02 2025-10-02 2025-11-03 2025-12-03 2026-01-02
ROE (TTM) -70.0% -70.0% -70.0% -70.0% -87.2% -87.2%
P/E (TTM) — — — — — —
Net Margin -503.9% -382.5% -382.5% -382.5% -447.6% -447.6%
Gross Margin 85.6% 89.4% 89.4% 89.4% 88.9% 88.9%
D/E Ratio 22.85 22.85 22.85 22.85 27.35 27.35
Current Ratio 10.09 10.09 10.09 10.09 7.85 7.85

Key Ratios

ROA (TTM)
-57.9%
P/S (TTM)
46.37
P/B
4.3
EPS (TTM)
$-1.44
CF/Share
$-0.83
Rev Growth 3Y
+13.6%
52W High
$16.44
52W Low
$5.79
$5.79 52-Week Range $16.44

How does OCUL compare to Pharmaceuticals peers?

Peer group: Mid-cap Pharmaceuticals ($2B+) · 25 companies

OCUL AMRX AVDL AXSM AZN

OCUL valuation vs Pharmaceuticals peers

P/E ratio
—
▼ 0% below peers (30.7)
vs Peers
vs Industry
Fair value
P/S ratio
46.4
▲ 590% above peers (6.7)
vs Peers
vs Industry
Overvalued
P/B ratio
4.3
▼ 18% below peers (5.2)
vs Peers
vs Industry
Pricier
Div yield
—
▼ 0% below peers (3.1%)
vs Peers
vs Industry
Low yield

OCUL profitability vs Pharmaceuticals peers

ROE
-87.2%
▼ 234% below peers (-26.1%)
vs Peers
vs Industry
Weak
Net margin
-447.6%
▼ 30768% below peers (-1.5%)
vs Peers
vs Industry
Weak
Gross margin
88.9%
▲ 0% above peers (88.9%)
vs Peers
vs Industry
Weak
ROA
-57.9%
▼ 512% below peers (-9.5%)
vs Peers
vs Industry
Weak

OCUL financial health vs Pharmaceuticals peers

D/E ratio
27.4
▲ 0% above peers (27.4)
vs Peers
vs Industry
In line
Current ratio
7.9
▲ 126% above peers (3.5)
vs Peers
vs Industry
Below avg
Beta
0.9
▲ 51% above peers (0.6)
vs Peers
vs Industry
More volatile

OCUL fundamentals radar

OCUL Peer median Industry

OCUL profitability vs leverage

Bubble size = market cap · X = net margin · Y = D/E ratio

OCUL vs peers: key metrics

Latest News

EyePoint sues rival Ocular Therapeutix, alleging false claims about eye drug
Yahoo Finance · Mar 22